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Abstract
Psoriasis vulgaris is defined by a series of linked cellular changes in the skin: hyperplasia of epidermal keratinocytes,
vascular hyperplasia and ectasia, and infiltration of T lymphocytes, neutrophils and other types of leukocytes in the
affected skin. Catechol-O-methyltransferase (COMT) 158 polymorphism can reduce the activity of the COMT en-
zymethatmaytriggerdefectivedifferentiationofkeratinocytesinpsoriasis.Immunocytescandegradeandinactivate
catecholamines via monamine oxidase (MAO) and COMT in the cells. We hypothesized that the COMT-158 G > A
polymorphism was associated with the risk of psoriasis vulgaris in Han Chinese people. In a hospital-based
case-control study, 524 patients with psoriasis vulgaris and 549 psoriasis-free controls were studied. COMT-158
G > A polymorphism was genotyped using the PCR sequence-specific primer (PCR-SSP) technique. We found no
statistically significant association between the COMT-158 allele A and the risk of psoriasis vulgaris (p = 0.739 ad-
justed OR = 1.03; 95% CI = 0.81-1.31). This suggests that the COMT-158 G > A polymorphism may not contribute to
the etiology of psoriasis vulgaris in the Han Chinese population.
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Psoriasis is a common skin disorder characterized by
the focal formation of inflamed, raised plaques that con-
stantly shed scales derived from excessive growth of epi-
thelial cells. The disease is defined by a series of linked
cellular changes in the skin: hyperplasia of epidermal kera-
tinocytes, vascular hyperplasia and ectasia and infiltration
of T lymphocytes, neutrophils, and other types of leuko-
cytes in the affected skin (Weinstein and Frost, 1968; Si-
monart and Heenen, 2007). The global incidence of the
disease is 1%-3% (Farber and Nall, 1974). Psoriasis is clin-
ically divided into type 1 (onset before 40 years of age) and
type 2 (onset after 40 years of age) (Henseler and Chris-
tophers, 1985; Ferrandiz et al., 2002).
Psoriasis is a T-cell mediated autoimmune process.
Activated lymphocytes, other immune accessory cells and
lymphokines have been detected in psoriatic plaques
(Dereure and Guilhou, 2003; Piruzian and Abdeev, 2006).
Several studies have suggested that T cells play a crucial
role in the pathogenesis of psoriasis (Bos et al., 1983;
Schlaak et al., 1994; Boehncke et al., 1996; Wrone-Smith
and Nickoloff, 1996; Gilhar et al., 1997; Yamamoto et al.,
1998; Bos and De Rie, 1999). T-cells accumulate early in
psoriatic plaques, and their cytokines induce abnormal ke-
ratinocyte proliferation. Catecholamine (CA) can also reg-
ulate immune functions. As early as in 1983, Bidart et al.
found that human T and B lymphocytes had catechol-
O-methyltransferase (COMT) immunoreactivity. Later,
Balsa et al. (1989) reported that monoamine oxide activity
(MOA) was present in human blood lymphocytes and
granulocytes. Treatment of lymphocytes with pargyline re-
sulted in an increase of intracellular CAs and a decrease of
intracellular CA metabolites in the lymphocytes (Kara-
yiorgou et al., 1997; Marino et al., 1999). CA metabolites
can be detected in immune cells (Yamamoto et al., 1998;
Cosentino et al., 2000). These results imply that immu-
nocytesnotonlysynthesizeCAs,butalsodegradeandinac-
tivate CAs via MAO and COMT in the cells. Previous
studies have found that epidermal homogenates from lesio-
nal psoriatic skin express higher levels of COMT activity
than those from normal skin. This could be due to a high
epidermal cell turnover or to an inborn error in the activity
of the enzyme (Bamshad et al., 1970).
Althoughthepathogenesisofpsoriasisisstillunclear,
many studies suggest that the disease has an exceedingly
complex genetic basis (Liu et al., 2007). Dimon-Gadal et
al. (2000) found that oxidative damage occurred before the
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Short Communicationappearance of typical psoriatic plaques, suggesting that
suchdamageisindependentofandmaypresentearlierthan
theinflammatoryinfiltration.Ithasbeenproposedthatoxi-
dativestressofnon-differentiatedkeratinocytestriggersthe
formationofadefectivehornylayer(ShilovandSergienko,
2000).
Catechol-O-methyltransferase(COMT)isanenzyme
that catalyses the O-methylation of biologically active
toxic catechols and plays an important role in the metabo-
lismofdrugsandneurotransmitters(Tursenetal.,2002).In
humans, the COMT protein exists as two length variants,
soluble (S-COMT) and membrane-bound (MB-COMT),
which are encoded by a single gene localized at chromo-
some 22q11.1-q11.2 (Grossman et al., 1992; Lundstrom et
al., 1995; Karayiorgou et al., 1997). The MB-COMT vari-
ant has an additional 50 amino acids at the N-terminal, but
isotherwiseidenticaltoS-COMT(Lundstrometal.,1991).
A single base-pair change (G > A) in exon 4 of the COMT
gene, resulting in an amino acid change (Val > Met) at
codon 158 of MB-COMT and codon 108 of S-COMT, re-
duces the thermostability and the activity of the enzyme
(Lotta et al., 1995; Lachman et al., 1996; Tursen et al.,
2002). The two alleles refer to COMT*H, the site-absent
(G; Val) allele that encodes the thermostable, high-activity
enzyme,andCOMT*L,thesite-present(A;Met)allelethat
encodes the thermolabile, low-activity enzyme. The allelic
variant only affects the enzyme activity (Palmatier et al.,
1999). A common single-nucleotide polymorphism (SNP)
in codon 158 of the COMT gene (COMT-158 G > A,
rs4680) codes for a substitution of valine (Val) by methio-
nine (Met), resulting in the reduced thermostability and ac-
tivity of the enzyme (Bertocci et al., 1991; Grossman et al.,
1992; Lundstrom et al., 1995; Karayiorgou et al., 1997).
Erdaletal.(2004),basedonacase-controlanalysisof
a Turkish population, observed that the COMT-158 G > A
polymorphism was significantly associated with genotype
COMT AA and psoriasis cases. They speculated that low
enzymeactivitycouldbeunabletopreventtheformationof
toxic o-quinones in psoriatics, and this oxidative stress of
keratinocytes could trigger defective differentiation in pso-
riasis. No differences have been found in COMT polymor-
phism between psoriatics and control subjects, but the
COMT-LL genotype was found significantly increased in
the psoriasis patients (Karayiorgou et al., 1997). COMT is
important in preventing the formation of toxic o-quinones
during epidermal cell synthesis. Therefore, COMT also
plays an important regulatory role in the oxidative damage
of keratinocytes. Immunocytes can degrade and inactivate
CAs via MAO and COMT in the cells (Qiu et al., 2005).
Based on this concept, we genotyped the COMT-158
A > G polymorphism in an ongoing hospital-based case-
controlstudyofpsoriasisvulgarisinaHanChinesepopula-
tion. The study sample consisted of 524 patients, 478 with
type1and46withtype2psoriasisvulgaris,and549control
subjectsrecruitedfromtheXijingHospital,FourthMilitary
Medical University, between August and December, 2005.
All cases were surveyed, but only Han Chinese (more than
90% of the Chinese population) patients and control sub-
jects were included in the analysis, because genotype fre-
quencies can vary among ethnic groups. The psoriasis-free
control subjects were persons who came to the hospital for
health examinations and did not have individual or family
historiesofpsoriasis.Allcasesandcontrolswereexamined
and diagnosed by dermatologists. We used a questionnaire
to collect demographic and other information [stage, type,
age of onset, psoriasis area and severity index (PASI)
scores], and matched the controls to the cases by age
(10 years) and gender. The response rates of patients and
controls approached for participation were both over 90%.
All subjects signed informed consent forms, and do-
nated 5 mL venous blood, used for genomic DNA extrac-
tion. This research protocol was approved by the ethics
review board of the Fourth Military Medical University.
Venous blood collected from each subject was added
to tubes containing 50 mmol EDTA/L, and genomic DNA
was isolated from 1 mL anti-coagulated peripheral blood
leukocytes using a DNA extraction kit (Taingen Biotech,
China).AfterDNAextraction,reactionswerecarriedoutin
a final volume of 20 L containing 100 ng DNA, 2.5 mM
MgCl2, 1.25 units of Taq DNA polymerase, 1 L of each
primer, 250 L dNTPs mixture, and 1X PCR buffer. All
PCR reaction reagents were purchased from Fermentas
(Lithuania). Genotyping for the G/A polymorphism was
carried out using polymerase chain reaction with se-
quence-specific primers (PCR-SSP). The following prim-
erswereusedtoamplifythetargetfragments:forCOMT-A,
5’-TggTggATTTCgCTggCA-3’(forward)and5’-ACACC
CATACAAgcaTTCATCAgTT-3’(reverse);forCOMT-G,
5’-gCATgCACACCTTgTCCTTCAC-3’ (forward) and
5’-TgAgCATAgAggCTAAgggACCAT-3’ (reverse). The
PCR conditions were as follows: preheating for 1 min at
96 °C to achieve a hot start, then a touch-down (TD) proce-
dureconsistingofdenaturationat96°Cfor20sandanneal-
ingat70°Cfor45sduringthefirstfivecycles,followedby
21cyclesof96°Cfor25s,65°Cfor50s,and72°Cfor30s
each, then 21 cycles at 96 °C for 30 s, 55 °C for 60 s, and
72 °C for 90 s, and a final extension at 20 °C for 2 min.
The size of the amplified PCR products was 455 bp
fortheCOMT-158Galleleand322bpfortheCOMT-158A
allele. These products were analyzed by 2% agarose gel
electrophoresis and visualized with 0.5 g/mL ethidium
bromide staining under an ultraviolet illuminator. Geno-
types were scored by two independent individuals, and any
ambiguous genotypes were repeated or omitted. PCR prod-
ucts were identified by sequencing.
Chi-square tests were used to evaluate the differences
in the frequency distributions of selected demographic
variables between the cases and controls, including each
allele and genotype of the COMT polymorphisms. Uncon-
ditional univariate and multivariate logistic regression
Gao et al. 33analyses were performed to obtain the crude and adjusted
odds ratios (ORs) for the risk of psoriasis and their 95%
confidence intervals (CIs). The multivariate adjustment in-
cluded age and gender variables. Two-tailed tests of statis-
tical significance were performed with SAS software
(version 8.2; SAS Institute, Inc., Cary, North Carolina).
Wefoundnosignificantdifferencesinageandgender
between the psoriasis patients and the control group: mean
age was 32.1  13.6 years in the psoriasis group and
31.513.9yearsinthecontrolgroup(p=0.232),whilethe
gender distributions (M:F) were 54.8%:45.2% in the study
group and 50.5%:49.5% in the control group (p = 0.157)
(Table 1).
The genotype and allele frequencies of COMT 158 in
the study and control groups are shown in Table 2. In the
control group, the genotype frequencies of the COMT 158
polymorphism were in agreement with the Hardy-
Weinberg equilibrium (p = 0.168). No significant differ-
ences were found between the psoriasis and control sub-
jects regarding the frequencies of genotypes GG, GA, and
AA (p = 0.759) (Table 2). Similarly, there was no signifi-
cant difference between the two groups regarding the fre-
quencies of allele A (p = 0.624).
To consider the single nucleotide polymorphism in
codon 158 (G > A)o ft h eCOMT gene, which leads to a
valine-methioninesubstitutionresultinginthedifferencein
COMT activity, we analyzed the association between com-
bined genotypes (GG, GA+AA) and the risk of psoriasis
vulgaris.Weinvestigatedwhetherthedistributionsofcom-
bined genotypes (GG, GA+AA) were different among type
1 and type 2 psoriasis patients and control subjects. How-
ever,asshowninTable3,thefrequencyofthevariantcom-
bined genotype (GA+AA) was not statistically different in
the type 1 psoriasis (43.5%) and type 2 psoriasis (47.8%)
cases compared to controls (43.0%).
The Psoriasis Area and Severity Index (PASI) is a
widely used method to characterize the severity of the dis-
ease (de Rie et al., 2004). In our study, PASI was used to
classifythepsoriaticpatientsintotwodifferentlevels:level
1 = PASI  20; level 2 = PASI > 20. As shown in Table 3,
the frequency of the variant combined genotype (GA+AA)
was 45.5% in level 1 and 41.5% in level 2 psoriasis pa-
tients. There was no statistical difference between the two
levels of psoriasis and the controls.
Based on previous research, we hypothesized that
polymorphism COMT 158 (G > A) might be associated
with the risk of psoriasis vulgaris. Our study, however,
found no significant association between COMT 158
(G > A) and psoriasis vulgaris, and also no significant dif-
ference between COMT 158 (G > A) and different types of
psoriasis vulgaris. Our study included only statistical re-
search, not functional investigation of the association be-
tween the COMT polymorphism and psoriasis vulgaris, so
this hypothesis needs to be tested by further functional
studies.
In conclusion, we found no significant difference re-
garding the COMT-158 (G > A) polymorphism between
psoriasis vulgaris patients and control subjects in a Han
Chinese population. The difference between these results
andthoseofErdaletal.(2004)maybeduetodifferencesin
the ethnic composition of the populations and in the num-
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Table 1 - Frequency distributions of selected variables in the psoriasis
cases and psoriasis-free controls.
Variables Cases (n = 524) Controls (n = 549) p
a
n% n%
Age (years) 0.232
 10 18 3.4 22 4.0
11-20 102 19.5 136 24.8
21-30 138 26.3 140 25.5
31-40 133 25.4 114 20.8
41-50 83 15.8 79 14.4
> 51 50 9.5 58 10.6
Gender 0.157
Male 287 54.8 277 50.5
Female 237 45.2 272 49.5
aTwo-sided 
2 test for the frequency distributions of selected variables be-
tween the cases and controls.
Table 2 - Genotype and allele frequencies of polymorphism COMT and associations with psoriasis risk.
Genotype Cases (N = 524) Controls (N = 549)
a p
b Crude OR
(95% CI)
Adjusted OR
(95% CI)
c
N% N%
GG 294 56.1 313 57.0 1.00 1.00
GA 201 38.4 211 38.4 0.759 1.02 (0.79-1.31) 1.00 (0.78-1.29)
AA 29 5.5 25 4.6 1.24 (0.71-2.16) 1.23 (0.70-2.15)
GA+AA 230 43.9 236 43.0 0.765 1.04 (0.82-1.33) 1.02 (0.80-1.31)
A allele 0.247 0.237 0.624
aThe genotype frequencies observed in the control subjects were in agreement with the Hardy-Weinberg equilibrium (
2 = 1.900, p = 0.168).
bTwo-tailed 
2 test for either genotype distributions or allele frequencies between the cases and controls.
cOdds ratios (ORs) were obtained from a logistic regression model with adjustment for age and gender; 95% confidence interval (CI).berofinvestigatedsubjects.Ourfindingssuggestthatpoly-
morphism COMT 158 may not be associated with the risk
of psoriasis vulgaris. Larger population-based studies, dif-
ferent clinical subgroups and studies among different eth-
nic groups are needed to confirm these findings.
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